PD2 Stock Overview
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Patterson Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$23.80 |
| 52 Week High | US$30.60 |
| 52 Week Low | US$21.80 |
| Beta | 1.05 |
| 1 Month Change | -4.80% |
| 3 Month Change | -14.39% |
| 1 Year Change | -0.83% |
| 3 Year Change | -11.85% |
| 5 Year Change | 23.52% |
| Change since IPO | 14.15% |
Recent News & Updates
Recent updates
Shareholder Returns
| PD2 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 7.2% | 1.8% |
| 1Y | -0.8% | 1.9% | 2.2% |
Return vs Industry: PD2 exceeded the German Healthcare industry which returned -3.9% over the past year.
Return vs Market: PD2 matched the German Market which returned -0.3% over the past year.
Price Volatility
| PD2 volatility | |
|---|---|
| PD2 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PD2 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PD2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1877 | 7,600 | Don Zurbay | www.pattersoncompanies.com |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.
Patterson Companies, Inc. Fundamentals Summary
| PD2 fundamental statistics | |
|---|---|
| Market cap | €2.18b |
| Earnings (TTM) | €181.92m |
| Revenue (TTM) | €6.16b |
12.0x
P/E Ratio0.4x
P/S RatioIs PD2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PD2 income statement (TTM) | |
|---|---|
| Revenue | US$6.57b |
| Cost of Revenue | US$5.17b |
| Gross Profit | US$1.40b |
| Other Expenses | US$1.20b |
| Earnings | US$193.86m |
Last Reported Earnings
Jan 27, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.16 |
| Gross Margin | 21.30% |
| Net Profit Margin | 2.95% |
| Debt/Equity Ratio | 81.7% |
How did PD2 perform over the long term?
See historical performance and comparison